Expression of vascular endothelial growth factor C and anti-angiogenesis therapy in endometriosis

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 11, 2014, Pages 7752-7759

  Song, Wei Wei ^a,b   Lu, Huan ^b   Hou, Wen Jing ^b   Xu, Guang Xu ^b   Zhang, Ji Hong ^b   Sheng, You Hua ^b   Cheng, Ming Jun ^c   Zhang, Rong ^b  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^b Department of Obstetrics and Gynecology Shanghai Jiaotong University Affiliated Sixth People Hospital South Campus ^*  (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

Angiogenesis; Endomertriosis; Endostar; Rat; Vegf c

Indexed keywords

ENDOSTAR PROTEIN; ENDOSTATIN; VASCULOTROPIN C;

ADULT; ANIMAL; DISEASE MODEL; DRUG EFFECTS; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; HUMAN; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PATHOLOGY; RAT; YOUNG ADULT;

ADULT; ANIMALS; DISEASE MODELS, ANIMAL; ENDOMETRIOSIS; ENDOMETRIUM; ENDOSTATINS; FEMALE; HUMANS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; RATS; VASCULAR ENDOTHELIAL GROWTH FACTOR C; YOUNG ADULT;

EID: 84920172115     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Bulun SE. Endometriosis. N Engl J Med 2009; 360: 268-279.
2. Leyland N, Casper R, Laberge P and Singh S. Endometriosis: diagnosis and management. J Obstet Gynaecol Can 2010; 32: S1-32.
3. Guo SW. Recurrence of endometriosis and its control. Hum Reprod Update 2009; 15: 441-461.
4. Rock J, Zacur H, Dlugi A, Jones H and TeLinde R. Pregnancy success following surgical correction of imperforate hymen and complete transverse vaginal septum. Obstet Gynecol 1982; 59: 448-451.
5. Berkley KJ, Dmitrieva N, Curtis KS and Papka RE. Innervation of ectopic endometrium in a rat model of endometriosis. Proc Natl Acad Sci U S A 2004; 101: 11094-11098.
6. Barnhart K, Dunsmoor-Su R and Coutifaris C. Effect of endometriosis on in vitro fertilization. Fertil Steril 2002; 77: 1148-1155.
7. Taylor R, Lebovic D and Mueller M. Angiogenic Factors in Endometriosis. Ann N Y Acad Sci 2002; 955: 89-100.
8. Becker C and D'Amato R. Angiogenesis and antiangiogenic therapy in endometriosis. Micro-vasc Res 2007; 74: 121-130.
9. Xu H, Zhang T, Man GC, May KE, Becker CM, Davis TN, Kung AL, Birsner AE, D'Amato RJ, Wong AW and Wang CC. Vascular endothelial growth factor C is increased in endometrium and promotes endothelial functions, vascular permeability and angiogenesis and growth of endometriosis. Angiogenesis 2013; 16: 541-551.
10. Laschke MW and Menger MD. Anti-angiogenic treatment strategies for the therapy of endometriosis. Hum Reprod Update 2012; 18: 682-702.
11. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril 1997; 67: 817-821.
12. Jones RC. The effect of a luteinizing hormone releasing hormone (LHRH) agonist (WY-40, 972), levonorgestrel, danazol and ovariectomy on experimental endometriosis in the rat. Acta Endocrinol Copenh 1984; 106: 282-288.
13. Groothuis PG, Nap AW, Winterhager E and Gr-ummer R. Vascular development in endometriosis. Angiogenesis 2005; 8: 147-156.
14. Ferrara N and Smyth TD. The Biology of Va-scular Endothelial Growth Factor. Endocr Rev 1997; 18: 4-25.
15. Ferrara N. Vascular endothelial growth factor and the regulation of angiogenesis. Recent Pr-og Horm Res 2000; 55: 15-35; discussion 35-16.
16. Bourlev V, Volkov N, Pavlovitch S, Lets N, La-rsson A and Olovsson M. The relationship between microvessel density, proliferative activity and expression of vascular endothelial growth factor-A and its receptors in eutopic endometrium and endometriotic lesions. Reproduction 2006; 132: 501-509.
17. Kim SH, Choi YM, Choung SH, Jun JK, Kim JG and Moon SY. Vascular endothelial growth factor gene +405 C/G polymorphism is associated with susceptibility to advanced stage endometriosis. Hum Reprod 2005; 20: 2904-2908.
18. Veikkola T and Alitalo K. VEGFs, receptors and angiogenesis. Sem Cancer Biol 1999; 9: 211-220.
19. Ferrara N. Vascular endothelial growth factor: molecular and biological aspects. Curr Top Microbiol Immunol 1999; 237: 1-30.
20. Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N and Alitalo K. A novel endothelial, growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. The EMBO Journal 1996; 15: 290-298.
21. Lee J, Gray A, Yuan J, Luoh S, Avraham H and Wood W. Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4. Proc Natl Acad Sci U S A 1996; 93: 1988-1992.
22. Mol BWJ, Bayram N, Lijmer JG, Wiegerinck MAHM, Veen MBF and Bossuyt PMM. The performance of CA-125 measurement in the detection of endometriosis:a meta-analysis. Fer-til Steril 1998; 70: 1101-1108.
23. Koninckx PR, Muyldermans M, Meuleman C and Comillie FJ. CA 125 in the management of endometriosis. Eur J Obstet Gynecol Reprod Biol 1993; 49: 109-113.
24. RICE VM. Conventional Medical Therapies for Endometriosis. Ann N Y Acad Sci 2002; 955: 343-352.
25. Xu H and Wang C. Angiogenesis and Anti-angiogenesis Therapy of Endometriosis. In: Mi-tchell LA (ed) Endometriosis: symptoms, diagnosis and treatments. New York: Nova Science; 2010. pp. 1-40.
26. Ribatti D. Endogenous inhibitors of angiogenesis: a historical review. Leuk Res 2009; 33: 638-644.
27. Nyberg P, Xie L and Kalluri R. Endogenous Inhi-bitors of Angiogenesis. Cancer Res 2005; 65: 3967-3979.
28. Kim Y, Jang J, Lee O, Yeon J, Choi E, Kim K, Lee S and Kwon Y. Endostatin Inhibits Endothelial and Tumor Cellular Invasion by Blocking the Activation and Catalytic Activity of Matrix Meta-lloproteinase 2. Cancer Res 2000; 60: 5410-5413.
29. Kim YM, Hwang S, Kim YM, Pyun BJ, Kim TY, Lee ST, Gho YS and Kwon YG. Endostatin blo-cks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1. J Biol Chem 2002; 277: 27872-27879.